Clinical Trial Update: Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating tacrolimus for treatment of systemic lupus erythematosus with membranous nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Membranous Nephropathy
• Systemic Lupus Erythematosus

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Lupus Nephritis, Lupus Erythematosus, Systemic | Phase 4 | Status: COMPLETED